Durable Capital Partners’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $228M | Sell |
1,040,648
-532,471
| -34% | -$117M | 1.72% | 25 |
|
|
2025
Q1 | $352M | Buy |
1,573,119
+935,721
| +147% | +$209M | 3.15% | 13 |
|
|
2024
Q4 | $209M | Sell |
637,398
-448,521
| -41% | -$147M | 1.7% | 23 |
|
|
2024
Q3 | $326M | Buy |
1,085,919
+45,395
| +4% | +$13.6M | 2.38% | 17 |
|
|
2024
Q2 | $343M | Buy |
1,040,524
+9,471
| +0.9% | +$3.12M | 2.81% | 12 |
|
|
2024
Q1 | $408M | Sell |
1,031,053
-107,677
| -9% | -$42.6M | 3.16% | 10 |
|
|
2023
Q4 | $401M | Sell |
1,138,730
-63,339
| -5% | -$22.3M | 3.17% | 12 |
|
|
2023
Q3 | $451M | Sell |
1,202,069
-76,506
| -6% | -$28.7M | 4.12% | 8 |
|
|
2023
Q2 | $489M | Buy |
1,278,575
+36,757
| +3% | +$14.1M | 4.29% | 6 |
|
|
2023
Q1 | $430M | Buy |
1,241,818
+128,134
| +12% | +$44.4M | 4.04% | 7 |
|
|
2022
Q4 | $262M | Sell |
1,113,684
-65,763
| -6% | -$15.5M | 2.72% | 15 |
|
|
2022
Q3 | $290M | Buy |
1,179,447
+185,411
| +19% | +$45.6M | 3.19% | 10 |
|
|
2022
Q2 | $301M | Buy |
994,036
+245,705
| +33% | +$74.3M | 3.45% | 9 |
|
|
2022
Q1 | $307M | Sell |
748,331
-110,879
| -13% | -$45.5M | 2.7% | 11 |
|
|
2021
Q4 | $403M | Hold |
859,210
| – | – | 3.15% | 10 |
|
|
2021
Q3 | $365M | Sell |
859,210
-92,053
| -10% | -$39.1M | 2.76% | 12 |
|
|
2021
Q2 | $342M | Sell |
951,263
-17,362
| -2% | -$6.23M | 2.52% | 15 |
|
|
2021
Q1 | $273M | Hold |
968,625
| – | – | 2.31% | 17 |
|
|
2020
Q4 | $274M | Sell |
968,625
-137,493
| -12% | -$39M | 2.44% | 17 |
|
|
2020
Q3 | $304M | Sell |
1,106,118
-135,073
| -11% | -$37.1M | 3.35% | 8 |
|
|
2020
Q2 | $282M | Buy |
1,241,191
+298,370
| +32% | +$67.8M | 3.51% | 6 |
|
|
2020
Q1 | $144M | Buy |
+942,821
| New | +$144M | 2.92% | 4 |
|